|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 696.00 TWD | -5.18% |
|
+2.20% | +75.31% |
| Market Cap | 57.65B 1.79B 1.54B 1.44B 1.32B 2.49B 170B 2.53B 16.92B 6.64B 85.15B 6.7B 6.56B 282B | P/E 2024 |
-14.5x | P/E 2025 | -23.9x |
|---|---|---|---|---|---|
| Enterprise Value | 41.38B 1.28B 1.11B 1.03B 949M 1.79B 122B 1.81B 12.14B 4.77B 61.12B 4.81B 4.71B 202B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.18% | ||
| 1 week | +2.20% | ||
| Current month | +2.20% | ||
| 1 month | +7.41% | ||
| 3 months | +77.10% | ||
| 6 months | +74.22% | ||
| Current year | +75.31% |
| 1 week | 660 |  | 768 |
| 1 month | 520 | | 773 |
| Current year | 331 | | 773 |
| 1 year | 149 | | 773 |
| 3 years | 70 | | 773 |
| 5 years | 70 | | 773 |
| 10 years | 27 | | 773 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheng Chi Wang
CEO | Chief Executive Officer | - | 01/06/2016 |
Wan Shan Chen
DFI | Director of Finance/CFO | 40 | 25/07/2022 |
Hung Wei Chen
COO | Chief Operating Officer | 45 | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Hsin Lin
CHM | Chairman | 48 | 13/10/2016 |
Cheng Chi Wang
BRD | Director/Board Member | - | 27/06/2024 |
Hui Chun Wang
BRD | Director/Board Member | 80 | 27/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.18% | +2.20% | +329.63% | +477.59% | 1.79B | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +0.50% | +0.78% | +63.34% | +87.64% | 362.26B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.86% | +64.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -744M -23.05M -19.94M -18.62M -17.08M -32.12M -2.19B -32.63M -218M -85.73M -1.1B -86.54M -84.65M -3.63B | -1.36B -42.2M -36.5M -34.09M -31.27M -58.82M -4.02B -59.75M -400M -157M -2.01B -158M -155M -6.66B |
| Net Debt | -5.17B -160M -139M -129M -119M -223M -15.25B -227M -1.52B -596M -7.64B -602M -589M -25.27B | -16.27B -504M -436M -407M -373M -702M -47.95B -713M -4.77B -1.87B -24.03B -1.89B -1.85B -79.45B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | NT$696.00 | -5.18% | 1,334,478 |
| 06/08/26 | NT$734.00 | +4.26% | 2,477,847 |
| 05/08/26 | NT$704.00 | +2.77% | 926,828 |
| 04/08/26 | NT$685.00 | -1.58% | 537,670 |
| 03/08/26 | NT$696.00 | +2.20% | 804,501 |
- Stock Market
- Stocks
- 6696 Stock
Select your edition
All financial news and data tailored to specific country editions
